SCHEMBL4229402

SCHEMBL4229402

CCOCCOc1cc(/C=C(/CC)C(=O)O)ccc1I

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
KDM4E B2RXH2 3/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
KMT2A Q03164 3/20 0.37
FDPS P14324 3/20 0.37
GAA P10253 1/20 0.37
TBXAS1 P24557 2/20 0.36
ALOX5 P09917 2/20 0.36
MEN1 O00255 2/20 0.35
APP P05067 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
LTB4R Q15722 1/20 0.34
LTB4R2 Q9NPC1 1/20 0.34
ALDH1A1 P00352 3/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4211074 0.88 FDPS (0.40) POLBKDM4EKMT2AFDPSMEN1
SCHEMBL4212795 0.88 ALOX5 (0.47) POLBKDM4EPSEN1PSEN2APH1B
SCHEMBL4220644 0.88 ALOX5 (0.47) POLBKDM4EPSEN1PSEN2APH1B
SCHEMBL4227793 0.88 ALOX5 (0.47) POLBKDM4EPSEN1PSEN2APH1B
SCHEMBL4607835 0.86 AKR1C3 (0.39) POLBKDM4EKMT2AFDPSGAA
SCHEMBL4218503 0.86 AKR1C3 (0.39) POLBKDM4EKMT2AFDPSGAA
SCHEMBL4223938 0.86 AKR1C3 (0.39) POLBKDM4EKMT2AFDPSGAA
SCHEMBL4218505 0.84 KDM4E (0.39) POLBKDM4EKMT2AFDPSGAA
SCHEMBL4229399 0.84 FDPS (0.41) POLBKDM4EKMT2AFDPSGAA
SCHEMBL4223934 0.84 KDM4E (0.39) POLBKDM4EKMT2AFDPSGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383652-B2 Biaromatic compounds that modulate PPAR-receptors GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-02-26 US disclosed
US-20090012129-A1 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-01-08 US disclosed
EP-1943213-A2 PPAR MODULATING BIAROMATIC COMPOUNDS Galderma Research & Development (FR) 2008-07-16 EP disclosed
WO-2007049158-A2 PPAR MODULATING BIAROMATIC COMPOUNDS GALDERMA RESEARCH & DEVELOPMENT (FR) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012129-A1 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS PPARG, PPARD, PPARA POLB 1106/4885KDM4E 2728/4885PSEN1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.